Eurasia Pharma and Healthcare: Navigating Sanctions and Covid
Multinational pharmaceutical companies often struggle in the Eurasia region, but for those that do navigate into these waters the rewards are a US$20 bln market.
Multinational pharmaceutical companies often struggle in the Eurasia region, but for those that do navigate into these waters the rewards are a US$20 bln market.
Healthcare was already a priority, even before Covid-19. Uzbekistan is a country in a hurry to modernize. It has already carried out a number of business and lifestyle changing reforms since the election of President Mirziyoyev in late 2016.
The privatization of state enterprises and efforts to attract more private investment into key parts of the economy are now important priorities for the president. Healthcare was identified as one of those priority industries even before the onset of the Covid-19 pandemic. The fact of the global pandemic
Copyright © 2022 Macro-Advisory Ltd. All Rights Reserved
Copyright © 2022 Macro-Advisory Ltd.
All Rights Reserved
Copyright © 2022 Macro-Advisory Ltd.
All Rights Reserved